EP 1267878 A2 20030102 - COMPOUNDS WITH 5-HT ACTIVITY USEFUL FOR CONTROLLING VISUAL FIELD LOSS
Title (en)
COMPOUNDS WITH 5-HT ACTIVITY USEFUL FOR CONTROLLING VISUAL FIELD LOSS
Title (de)
ARZNEIMITTEL MIT 5-HT AKTIVITÄT ZUR KONTROLIERUNG DER GESICHTFELDSVERLORUNG
Title (fr)
COMPOSES A ACTIVITE AGONISTE SUR LE RECEPTEUR 5-HT UTILISES POUR ENRAYER LA PERTE DU CHAMP VISUEL
Publication
Application
Priority
- US 0105740 W 20010223
- US 19027900 P 20000317
Abstract (en)
[origin: WO0170230A2] Compounds with 5-HT1A agonist activity which are useful for controlling the visual field loss associated with glaucoma are disclosed.
IPC 1-7
IPC 8 full level
C07D 211/70 (2006.01); A61K 31/137 (2006.01); A61K 31/36 (2006.01); A61K 31/404 (2006.01); A61K 31/4045 (2006.01); A61K 31/425 (2006.01); A61K 31/4418 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); A61K 31/5575 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 9/10 (2006.01); A61P 25/02 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); A61P 43/00 (2006.01); C07D 209/08 (2006.01); C07D 209/16 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP KR)
A61K 31/36 (2013.01 - EP); A61K 31/4045 (2013.01 - EP); A61K 31/506 (2013.01 - KR); A61P 9/10 (2018.01 - EP); A61P 25/02 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 27/06 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0170230 A2 20010927; WO 0170230 A3 20020425; AR 028258 A1 20030430; AT E247507 T1 20030915; AU 2001245310 B2 20050317; AU 2005202600 A1 20050707; AU 2005202600 B2 20080731; AU 3855201 A 20011003; AU 3983601 A 20011003; AU 4531001 A 20011003; BR 0109193 A 20030527; BR 0109211 A 20030211; BR 0109230 A 20030603; CA 2399985 A1 20010927; CA 2400637 A1 20010927; CA 2400639 A1 20010927; CA 2400639 C 20110816; CN 1198605 C 20050427; CN 1418100 A 20030514; CN 1418121 A 20030514; DE 60100625 D1 20030925; DE 60100625 T2 20040226; DK 1263504 T3 20031208; EP 1263434 A1 20021211; EP 1263504 A2 20021211; EP 1263504 B1 20030820; EP 1267878 A2 20030102; ES 2204848 T3 20040501; HK 1051504 A1 20030808; JP 2003527422 A 20030916; JP 2003527423 A 20030916; JP 2003527427 A 20030916; JP 2011037901 A 20110224; JP 2011153158 A 20110811; JP 4789231 B2 20111012; KR 100749191 B1 20070813; KR 20020082885 A 20021031; KR 20030009390 A 20030129; KR 20030016239 A 20030226; MX PA02009071 A 20030523; MX PA02009072 A 20030312; MX PA02009073 A 20030312; PL 203709 B1 20091130; PL 358306 A1 20040809; PT 1263504 E 20031231; TW I268777 B 20061221; WO 0170222 A2 20010927; WO 0170222 A3 20020725; WO 0170223 A1 20010927; ZA 200206350 B 20030808
DOCDB simple family (application)
US 0105740 W 20010223; AR P010101211 A 20010315; AT 01918208 T 20010223; AU 2001245310 A 20010223; AU 2005202600 A 20050615; AU 3855201 A 20010220; AU 3983601 A 20010223; AU 4531001 A 20010223; BR 0109193 A 20010220; BR 0109211 A 20010223; BR 0109230 A 20010223; CA 2399985 A 20010223; CA 2400637 A 20010220; CA 2400639 A 20010223; CN 01806620 A 20010223; CN 01806764 A 20010223; DE 60100625 T 20010223; DK 01918208 T 20010223; EP 01911005 A 20010220; EP 01914447 A 20010223; EP 01918208 A 20010223; ES 01918208 T 20010223; HK 03103444 A 20030515; JP 2001568420 A 20010223; JP 2001568421 A 20010220; JP 2001568428 A 20010223; JP 2010261857 A 20101124; JP 2011108785 A 20110513; KR 20027012169 A 20020916; KR 20027012170 A 20020916; KR 20027012171 A 20020916; MX PA02009071 A 20010220; MX PA02009072 A 20010223; MX PA02009073 A 20010223; PL 35830601 A 20010223; PT 01918208 T 20010223; TW 90106235 A 20010316; US 0105432 W 20010220; US 0105700 W 20010223; ZA 200206350 A 20020808